• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
What Are the Most Powerful Immunogen Design Vaccine Strategies? A Structural Biologist's Perspective.最有效的免疫原设计疫苗策略是什么?结构生物学家的观点。
Cold Spring Harb Perspect Biol. 2017 Nov 1;9(11):a029470. doi: 10.1101/cshperspect.a029470.
2
What Are the Most Powerful Immunogen Design Vaccine Strategies? Reverse Vaccinology 2.0 Shows Great Promise.什么是最有效的免疫原设计疫苗策略?反向疫苗学 2.0 展现出巨大的潜力。
Cold Spring Harb Perspect Biol. 2017 Nov 1;9(11):a030262. doi: 10.1101/cshperspect.a030262.
3
Structure-Based Vaccine Antigen Design.基于结构的疫苗抗原设计。
Annu Rev Med. 2019 Jan 27;70:91-104. doi: 10.1146/annurev-med-121217-094234.
4
Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen.用异源DNA初免-改良安卡拉痘苗病毒加强的HIV-1疫苗方案接种后对保守的Gag区域的优先靶向作用
J Virol. 2017 Aug 24;91(18). doi: 10.1128/JVI.00730-17. Print 2017 Sep 15.
5
Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines.包膜病毒的共同特征及其对下一代疫苗免疫原设计的意义。
Cell. 2018 Mar 8;172(6):1319-1334. doi: 10.1016/j.cell.2018.02.054.
6
The new generation of recombinant viral subunit vaccines.新一代重组病毒亚单位疫苗。
Curr Opin Biotechnol. 1996 Dec;7(6):646-52. doi: 10.1016/s0958-1669(96)80077-2.
7
Uses of vaccinia virus in vaccine delivery.痘苗病毒在疫苗递送中的应用。
Curr Opin Biotechnol. 1994 Oct;5(5):501-4. doi: 10.1016/0958-1669(94)90064-7.
8
Structure-based design for high-hanging vaccine fruits.基于结构的高挂疫苗果实设计。
Adv Immunol. 2012;114:33-50. doi: 10.1016/B978-0-12-396548-6.00002-0.
9
Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses.针对高变异病毒的基于肽的疫苗的创新生物信息学方法。
Immunol Cell Biol. 2011 Jan;89(1):81-9. doi: 10.1038/icb.2010.65. Epub 2010 May 11.
10
Design of immunogens as components of a new generation of molecular vaccines.作为新一代分子疫苗组成部分的免疫原设计。
J Biotechnol. 1996 Jan 26;44(1-3):129-37. doi: 10.1016/0168-1656(95)00089-5.

引用本文的文献

1
The Question of HIV Vaccine: Why Is a Solution Not Yet Available?HIV 疫苗问题:为什么尚未找到解决方案?
J Immunol Res. 2024 Apr 8;2024:2147912. doi: 10.1155/2024/2147912. eCollection 2024.
2
Structures and immune recognition of Env trimers from two Asia prevalent HIV-1 CRFs.两种亚洲流行的 HIV-1 型 CRF 的 Env 三聚体的结构和免疫识别。
Nat Commun. 2023 Aug 4;14(1):4676. doi: 10.1038/s41467-023-40321-x.
3
Computational Methods in Immunology and Vaccinology: Design and Development of Antibodies and Immunogens.免疫与疫苗学的计算方法:抗体和免疫原的设计与开发。
J Chem Theory Comput. 2023 Aug 22;19(16):5315-5333. doi: 10.1021/acs.jctc.3c00513. Epub 2023 Aug 1.
4
Pan-neutralizing, germline-encoded antibodies against SARS-CoV-2: Addressing the long-term problem of escape variants.针对 SARS-CoV-2 的泛中和、种系编码抗体:应对逃逸变异的长期问题。
Front Immunol. 2022 Oct 28;13:1032574. doi: 10.3389/fimmu.2022.1032574. eCollection 2022.
5
HIV and SARS-CoV-2: Tracing a Path of Vaccine Research and Development.HIV 和 SARS-CoV-2:疫苗研发的溯源之路。
Curr HIV/AIDS Rep. 2022 Feb;19(1):86-93. doi: 10.1007/s11904-021-00597-4. Epub 2022 Jan 28.
6
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants.基于刺突糖蛋白的 SARS-CoV-2 疫苗及新病毒变异株的影响。
Front Immunol. 2021 Jul 12;12:701501. doi: 10.3389/fimmu.2021.701501. eCollection 2021.
7
Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization.免疫接种诱导的抗体驱动 HIV 包膜糖蛋白三聚体免疫原的解体。
Sci Adv. 2021 Jul 28;7(31). doi: 10.1126/sciadv.abh2791. Print 2021 Jul.
8
Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization.HIV包膜糖蛋白三聚体免疫原的解体是由免疫接种引发的抗体驱动的。
bioRxiv. 2021 Feb 17:2021.02.16.431310. doi: 10.1101/2021.02.16.431310.
9
Biological characteristics and biomarkers of novel SARS-CoV-2 facilitated rapid development and implementation of diagnostic tools and surveillance measures.新型 SARS-CoV-2 的生物学特性和生物标志物促进了诊断工具和监测措施的快速开发和实施。
Biosens Bioelectron. 2021 Apr 1;177:112969. doi: 10.1016/j.bios.2021.112969. Epub 2021 Jan 4.
10
The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens.SARS-CoV-2 刺突糖蛋白的生物合成、结构、功能和抗原性:对基于刺突的疫苗免疫原设计的启示。
Front Immunol. 2020 Oct 7;11:576622. doi: 10.3389/fimmu.2020.576622. eCollection 2020.

本文引用的文献

1
Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV.基于结构的迭代改进抗呼吸道合胞病毒融合糖蛋白疫苗
Nat Struct Mol Biol. 2016 Sep;23(9):811-820. doi: 10.1038/nsmb.3267. Epub 2016 Aug 1.
2
Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses.可中和1型和2型甲型流感病毒的疫苗诱导抗体。
Cell. 2016 Jul 28;166(3):609-623. doi: 10.1016/j.cell.2016.06.043. Epub 2016 Jul 21.
3
Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch.早期抗体谱系多样化和独立肢体成熟导致针对Env高甘露糖补丁的广泛HIV-1中和作用。
Immunity. 2016 May 17;44(5):1215-26. doi: 10.1016/j.immuni.2016.04.016.
4
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody.作为中和抗体易损位点的HIV-1融合肽。
Science. 2016 May 13;352(6287):828-33. doi: 10.1126/science.aae0474.
5
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody.从种系到CD4模拟抗体的广泛HIV-1中和剂的成熟途径
Cell. 2016 Apr 7;165(2):449-63. doi: 10.1016/j.cell.2016.02.022. Epub 2016 Mar 3.
6
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design.HIV-1包膜蛋白V1V2区与广泛中和抗体的结构揭示了有助于疫苗设计的共性。
Nat Struct Mol Biol. 2016 Jan;23(1):81-90. doi: 10.1038/nsmb.3144. Epub 2015 Dec 21.
7
Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera.融合前F特异性抗体决定了人血清中呼吸道合胞病毒(RSV)中和活性的大小。
Sci Transl Med. 2015 Oct 14;7(309):309ra162. doi: 10.1126/scitranslmed.aac4241.
8
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen.稳定的三聚体流感血凝素茎作为一种广泛保护性的免疫原。
Science. 2015 Sep 18;349(6254):1301-6. doi: 10.1126/science.aac7263. Epub 2015 Aug 24.
9
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection.血凝素茎纳米颗粒产生异源型流感保护。
Nat Med. 2015 Sep;21(9):1065-70. doi: 10.1038/nm.3927. Epub 2015 Aug 24.
10
A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age.一项在健康育龄期女性中进行的呼吸道合胞病毒重组融合(F)纳米颗粒疫苗的随机、双盲、对照、剂量范围研究。
J Infect Dis. 2016 Feb 1;213(3):411-22. doi: 10.1093/infdis/jiv406. Epub 2015 Aug 10.

最有效的免疫原设计疫苗策略是什么?结构生物学家的观点。

What Are the Most Powerful Immunogen Design Vaccine Strategies? A Structural Biologist's Perspective.

机构信息

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892.

出版信息

Cold Spring Harb Perspect Biol. 2017 Nov 1;9(11):a029470. doi: 10.1101/cshperspect.a029470.

DOI:10.1101/cshperspect.a029470
PMID:28159876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5666634/
Abstract

The ability of structure-based design to control the shape and reactivity-the atomic-level chemistry-of an immunogen argues for it being one of the "most powerful" immunogen-design strategies. But antigenic reactivity is only one of the properties required to induce a protective immune response. Here, a multidimensional approach is used to exemplify the enabling role atomic-level information can play in the development of immunogens against three viral pathogens, respiratory syncytial virus, influenza A virus, and human immunodeficiency virus (HIV), which have resisted standard approaches to vaccine development. Overall, structure-based strategies incorporating B-cell ontogenies and viral evasion mechanisms appear exceptionally powerful.

摘要

基于结构的设计能够控制免疫原的形状和反应性——即原子水平的化学性质——这使得它成为“最强大”的免疫原设计策略之一。但是,抗原反应性只是诱导保护性免疫应答所必需的特性之一。在这里,采用多维方法来说明原子水平信息在开发针对三种病毒病原体(呼吸道合胞病毒、甲型流感病毒和人类免疫缺陷病毒(HIV))的免疫原方面可以发挥的作用,这些病原体对疫苗开发的标准方法有抵抗力。总的来说,包含 B 细胞发生和病毒逃逸机制的基于结构的策略似乎格外强大。